How to Market a Patent: Buyers, Package, Outreach

Search how to market a patent and you get product marketing with the nouns swapped. Build a website for the invention. Post on LinkedIn. Go to trade shows. List it on a marketplace. That playbook is written for things that sell to thousands of customers. A patent sells or licenses to a handful of companies, usually fewer than ten, and nearly all of them can be named before you write a word. Marketing a patent is therefore closer to running a small M&A process than to running a campaign. Here is that process in the order a broker runs it, including the parts the ranking pages leave out. ## Why the usual advice does not sell patents Visibility does not create demand for a patent. More than 90 percent of properties find buyers in the real estate secondary market, and more than 90 percent of patents do not transact at all. The mechanism is not a marketing failure. An uninfringed patent has little or no value until the industry catches up with the invention, because a patent is a right to exclude, and if nobody needs excluding there is nothing to buy. So the job of marketing a patent is narrow. Find the few companies for whom the right to exclude already has a price, and put an evidence package in front of the right person there. Patents rarely sell themselves; the most natural buyers and licensees are companies already operating in the invention's space, competitors, suppliers and manufacturers who would benefit from the technology or who risk infringing it. A website does not find those companies. Research does. ## Step one: name the buyer universe before you write a word ### Three pools Your targets fall into three groups, and they need different handling. Competitors already making products that arguably read on your claims face real risk and have an obvious reason to license. Companies that could benefit but are not yet using the technology are the expansion play, harder to find and often more cooperative. Entities already implementing without authorisation are infringers, and also the most likely to deny infringement, challenge validity and turn a pitch into a litigation threat. Write the three lists separately. The third list is approached last, with counsel, for reasons covered in step four. A fuller taxonomy of who actually buys patents is its own subject. ### Signals that shorten the list Three public records do most of the work. Forward citations first: a company that cited your patent as prior art during its own prosecution has told the world, in writing, that it knows about your technology. Then the register: the USPTO assignment database shows who licenses what, and companies that have licensed patents before are more likely to license again. Then the value chain. Sometimes the best licensees are not the most obvious ones; component suppliers, software developers or service providers can offer better licensing opportunities than end-product manufacturers. Then cut. A targeted approach to five well-researched companies produces better results than a mass mailing to fifty. Start with three to five. ### Territory sets the ceiling Patent rights are territorial. A US patent stops nothing in Germany, and a German patent stops nothing in Ohio. If you hold only US rights, your universe is companies that make, use or sell in the United States. If you hold a European family too, multinational manufacturers become viable targets. The territorial reach you actually own is the territorial reach you can sell, which is why a buyer's first diligence question is often the family listing rather than the claims. ## Step two: build the package an engineer can evaluate in ten minutes ### The one-pager The single most important document in the process fits on one page, two sides at most. It carries a problem statement in the target company's terms, the solution at the functional level rather than the mechanism, two or three quantitative data points, patent status in one sentence, the commercial proposition in one sentence, and a contact line. The status sentence is where honesty costs nothing and evasion costs everything. Write "US patent granted, European application pending" exactly as it stands. Status also sets the discount. A granted patent with strong claims is a far easier sell than a pending application or a patent with narrow coverage. Buyers can and do acquire pending rights, and some prefer to shape prosecution, but selling while the application is still pending prices examination risk into the number. ### The claims chart A claims chart maps the company's product, or its competitor's product, against your independent claims element by element. It is the document that turns patent language into commercial relevance. Prepare it before the first email. Do not lead with it. It comes out during technical discussions, after someone on their side has decided the problem is real. ### What stays out of the first message The initial message should generate interest and secure a preliminary conversation, not hand over enough detail for the recipient to design around the patent. The published application is already public, so what you protect is the material around it: the chart, the test data, unfiled continuations, and your price floor. ## Step three: reach the person who builds, not the person who defends ### Who to write to The instinct is to find the Legal or Licensing tab on the company website. Do not do this. Legal departments are trained to protect the company, not to innovate, and an email that starts there is often seen as a liability risk; target engineering leaders, product managers or innovation teams, the people who know the roadmap and can say "we need this". In practice that means a VP of Engineering, a Director of Business Development, a Head of Technology Licensing, or in a smaller company the CEO directly. Never the general inbox, never purchasing. Spend ten minutes on every individual before you write. Read the engineering blog, the recent product announcement, the conference talk. If the email could have been sent to any company in the industry, it is not specific enough to get a reply. ### What the message says Four moves, in order: the problem your invention clears, stated as their problem; the relevance to something they shipped or announced; the credibility, which is where the patent appears as support rather than headline; and a low-pressure ask for a conversation rather than a meeting or a deal. Three short paragraphs with the one-pager attached. The subject line decides whether any of it is read. "Patent opportunity" and "Licensing proposal" look like spam or legal notices. "Patented heat sink technology, 30 percent thermal improvement for LED fixtures" gets opened, because it reads like a peer sharing something relevant. ### Portals, introductions and trade shows Large companies often run formal technology submission portals. Use them when they exist, but never alone: reviews can take months and many submissions never get a reply, so run a parallel approach to a named person in the licensing or engineering team. Warm introductions through industry connections receive more attention than cold outreach, particularly at corporations that field many proposals. Trade shows work when you choose the companies before the event, visit the booth, examine the products and ask informed questions about their technical challenges. If the conversation develops, offer to send the one-pager. Booth staff are there to sell, not to evaluate, so an ambush with a full pitch converts nobody. ## Step four: sequence the conversations Order matters more than most pages admit. Sophisticated licensors build a roster of willing licensees first. That roster establishes a going royalty rate, and a patent licensed by five willing companies at 5 percent is a far more intimidating thing to a holdout than a patent licensed by nobody. Only then do they turn to the companies already practising without permission. Approach that third pool with care and with counsel. An aggressive demand letter can trigger a declaratory judgment suit in a forum you did not choose; the Supreme Court's MedImmune decision in 2007 opened that door wider than many inventors realise. Whatever the pool, do not accuse anyone of infringement in the first message. Accusations create defensiveness, and the productive conversations start as business discussions about mutual benefit. Then keep momentum. A company that is enthusiastic in week one may have moved on by week six, so follow up weekly with a clear next step: a technical call, a mutual NDA, a site visit, a term sheet. Structure gives you room to run several conversations at once. Licences can be sliced by exclusivity, field of use and territory, so the same patent can go exclusively to one partner in aerospace, non-exclusively in automotive, and stay untouched in medical devices. That choice, and whether to license or sell at all, belongs in the package before outreach starts, and how the transfer itself closes is the half of the process a signed term sheet still has to survive. ## What marketing a patent should cost ### Doing it yourself Run the first two or three approaches yourself. You learn how companies actually respond to your technology, and you refine the pitch on real feedback rather than on theory. The cost is time and the ten minutes of research per contact. ### Agents and brokers If the market turns out to have many potential licensees and you want to scale, a licensing agent typically charges 15 to 30 percent commission and brings contacts and negotiation experience. Brokers who handle marketing, valuation and negotiation for a sale sit in a similar band, taking 15 to 30 percent of licensing revenue, against royalties that typically run 2 to 5 percent of sales for consumer products and higher for specialised technology. The practitioner literature puts broker success fees at 20 to 35 percent and justifies them by the illiquidity above: the fee buys access to buyers you cannot reach. The arithmetic of what patent brokers charge is simple. A share of a sale that happens beats all of one that does not, provided the intermediary can reach people you cannot. ### The invention promotion trap This query sits next to a low-trust neighbourhood, and it is worth saying so. The USPTO does not investigate complaints against invention promoters or promotion firms, but under the American Inventors Protection Act of 1999 it publishes complaints and the firms' responses in a public forum, points inventors to the FTC's record of actions such as FTC v. World Patent Marketing and FTC v. Davison & Associates, and advises being wary of any firm that promises too much or costs too much. The structural rule behind that warning: anyone paid upfront to market your patent has no incentive to tell you it will not sell. A success fee is the only pricing that puts the intermediary on your side of the question. ## How we market a patent We run brokerage as the process above rather than as a listing, so our economics belong here in plain terms. Commission is paid by the seller on completion, with a minimum fee of EUR 5,000 per completed transaction, and no sale means no fee. An optional retainer is credited on close. The work that changes outcomes happens before step three. Every asset passes a validation gate first: physics-grade claim reconstruction, detectability analysis and validity probability, benchmarked at 0.76 percent mean absolute percentage error against real-world outcomes. Detectability is the marketing question in disguise. A claim you cannot show is being practised is a claim no outreach can sell, and finding that out before the first email is cheaper than finding it out after the fifth. Two limits in the same breath. EX-IX is not a firm of patent attorneys, and a novelty search does not guarantee grant or patentability; attorney work runs through an independent licensed attorney of record. And no intermediary, us included, can promise a buyer. What a process can promise is that the buyers who exist were found and reached properly, which is a different thing from which route fits what you are holding in the first place. ## FAQ Should I market my patent before it is granted? You can. Applications are assignable and licensable, and some buyers prefer to acquire early so they can shape prosecution. Expect a discount for examination risk, and write "pending application" in the one-pager exactly as it stands. Implying grant is the fastest way to lose a buyer's trust in everything else you have said. Can I tell a company about my patent without an NDA? What the published application discloses is already public, so an NDA for the invention itself protects nothing. Use one for what the patent does not show: the claims chart, test data, unfiled continuations and your price floor. Ask for the NDA at the point where the conversation moves from interest to technical review. How many companies should I contact at once? Three to five, each with a one-pager customised to its product line and a named recipient you have researched. Momentum across a few live conversations beats reach across fifty cold ones, and the feedback from the first three tells you how to pitch the next ten. What if the only interested company is already using my invention? That is the most fraught conversation in the process. Do not accuse in the first message, do not send a demand letter without counsel, and if any willing licensee exists sign them first so a going royalty rate is on record before the holdout conversation begins. Is a corporate submission portal worth using? As one channel, yes. As the only channel, no. Portal reviews take months and many submissions never receive a reply, so file the submission and in parallel write to a named engineering or licensing contact at the same company.